
Seranti Pharmaceuticals Private Limited
Manufactures and trades pharmaceutical and medicine products, acts as agents and distributors.
Manufactures and trades pharmaceutical and medicine products, acts as agents and distributors.
Seranti Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 2010 and has a history of 14 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.16 M.
The company currently has active open charges totaling ₹4.72 M. The company has closed loans amounting to ₹1.85 M, as per Ministry of Corporate Affairs (MCA) records.
Ahuti Rautaray and Susanta Senapati serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24233TG2010PTC071088
071088
Private Limited Indian Non-Government Company
04 Nov 2010
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ahuti Rautaray ![]() | Managing Director | 04-Nov-2010 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Susanta Senapati ![]() | Director | 14-Dec-2020 | Current |
Seranti Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.32% increase. The company also saw a slight improvement in profitability, with a 3.23% increase in profit. The company's net worth moved up by a moderate rise of 4.77%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Seranti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹4.72 M
₹1.85 M
Date | Lender | Amount | Status |
---|---|---|---|
30 Apr 2022 | Others | ₹0.24 M | Open |
30 Apr 2022 | Others | ₹0.48 M | Open |
31 May 2016 | Others | ₹4.00 M | Open |
20 Aug 2014 | Syndicate Bank | ₹1.35 M | Satisfied |
05 Dec 2013 | Oriental Bank Of Commerce | ₹0.50 M | Satisfied |
Seranti Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Seranti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seranti Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Seranti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Seranti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with Others of Rs. 4.00 M registered on 31 May 2016 with Charge ID 100038369 was modified on 24 Jun 2023.
A charge with Others amounted to Rs. 0.24 M with Charge ID 100569552 was registered on 30 Apr 2022.
A charge with Others amounted to Rs. 0.48 M with Charge ID 100569553 was registered on 30 Apr 2022.
Susanta Senapati was appointed as a Director was appointed as a Director on 14 Dec 2020 & has been associated with this company since 4 years 5 months .
Seranti Pharmaceuticals Private Limited was incorporated on 04 Nov 2010.
The authorized share capital of Seranti Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.16 M.
Currently 2 directors are associated with Seranti Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Seranti Pharmaceuticals Private Limited is 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda India, Secunderabad, Telangana, 500010.
The corporate identification number (CIN) of Seranti Pharmaceuticals Private Limited is U24233TG2010PTC071088 and the company number is 071088 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Seranti Pharmaceuticals Private Limited has risen by 12.32%.
The financial reports for the fiscal year 2023 indicates that The net worth of Seranti Pharmaceuticals Private Limited has experienced an upsurge of 4.77%.
As per the financial statements for fiscal Year 2023, The total open charges for Seranti Pharmaceuticals Private Limited amount to ₹ 4.72 M.
The most recent Balance Sheet for Seranti Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
MS